MarketBeat Instant News Alerts 2 hours agoAllstate (NYSE:ALL) Issues Earnings ResultsMarketBeatAllstate (NYSE:ALL - Get Free Report) announced its quarterly earnings results on Wednesday. The insurance provider reported $9.76 EPS for the quarter, beating analysts' consensus estimates of $6.89 by $2.87. Allstate had a return on equity of 41.64% and a net margin of 18.97%. The firm had revenue of $17.35 billion for the quarter, compared to analyst estimates of $15.87 billion. NYSE:ALLRead Allstate (NYSE:ALL) Issues Earnings Results2 hours agoAlbemarle (NYSE:ALB) Announces Quarterly Earnings ResultsMarketBeatAlbemarle (NYSE:ALB - Get Free Report) released its quarterly earnings data on Wednesday. The specialty chemicals company reported $2.58 earnings per share for the quarter, topping the consensus estimate of $2.53 by $0.05. Albemarle had a net margin of 3.09% and a return on equity of 10.96%. The firm had revenue of $1.55 billion for the quarter, compared to analyst estimates of $1.52 billion. NYSE:ALBRead Albemarle (NYSE:ALB) Announces Quarterly Earnings Results2 hours agoAflac (NYSE:AFL) Issues Quarterly Earnings ResultsMarketBeatAflac (NYSE:AFL - Get Free Report) announced its earnings results on Wednesday. The financial services provider reported $2.43 EPS for the quarter, beating analysts' consensus estimates of $1.80 by $0.63. Aflac had a net margin of 26.91% and a return on equity of 13.27%. The firm had revenue of $3.27 billion for the quarter, compared to analysts' expectations of $4.12 billion. NYSE:AFLRead Aflac (NYSE:AFL) Issues Quarterly Earnings Results2 hours agoTravere Therapeutics (NASDAQ:TVTX) Price Target Raised to $72.00MarketBeatCanaccord Genuity Group lifted their price objective on Travere Therapeutics from $70.00 to $72.00 and gave the company a "buy" rating in a research report on Wednesday.NASDAQ:TVTXRead Travere Therapeutics (NASDAQ:TVTX) Price Target Raised to $72.002 hours agoSprout Social (NASDAQ:SPT) Price Target Raised to $13.50MarketBeatCanaccord Genuity Group increased their price target on Sprout Social from $10.00 to $13.50 and gave the stock a "hold" rating in a research note on Wednesday.NASDAQ:SPTRead Sprout Social (NASDAQ:SPT) Price Target Raised to $13.502 hours agoUltragenyx Pharmaceutical (NASDAQ:RARE) Stock Price Target Lowered at Canaccord Genuity GroupMarketBeatCanaccord Genuity Group dropped their target price on Ultragenyx Pharmaceutical from $39.00 to $34.00 and set a "buy" rating on the stock in a report on Wednesday.NASDAQ:RARERead Ultragenyx Pharmaceutical (NASDAQ:RARE) Stock Price Target Lowered at Canaccord Genuity Group Trending News1Fermi Advances Project Matador, Pivots to Powered-Land Strategy as Director Vote Fails2Compass Pathways (NASDAQ:CMPS) Stock Falls 7.1% - Should You Sell?320,118 AST SpaceMobile, Inc. $ASTS Shares Acquired by International Assets Investment Management LLC4Sandisk Stock Set to Split on Friday, November 20th (NASDAQ:SNDK)5110,309 Shares of MNTN Inc. $MNTN Bought by One Way Holdings LLC6Partners Wealth Management LLC Purchases New Holdings in ExxonMobil Corporation $XOM7Apple Q4 Earnings Call Highlights8Sable Offshore (SOC) Projected to Post Earnings on Monday All MarketBeat Instant News Alerts Latest News Trending News Sort By Last 24 Hours Last 3 Days Last 5 Days Last 7 Days Last 14 Days Last 30 Days Last 90 Days All Time Time Frame All Alerts Analyst Congressional Trades Consensus Corporate Buyback Corporate Event Transcript Dividend Earnings Earnings Preview Earnings Transcript Highlights Estimates Guidance Insider Trade Lockup Expiration MarketBeat List Articles Options Price SEC Filing Stock List Stock Split Alert Type Keywords More filters Fewer filters Done 2 hours agoCanaccord Genuity Group Issues Positive Forecast for Madrigal Pharmaceuticals (NASDAQ:MDGL) Stock PriceMarketBeatNASDAQ:MDGLRead Canaccord Genuity Group Issues Positive Forecast for Madrigal Pharmaceuticals (NASDAQ:MDGL) Stock Price2 hours agoHealthStream (NASDAQ:HSTM) Given New $32.00 Price Target at Canaccord Genuity GroupMarketBeatNASDAQ:HSTMRead HealthStream (NASDAQ:HSTM) Given New $32.00 Price Target at Canaccord Genuity Group2 hours agoCanaccord Genuity Group Issues Pessimistic Forecast for Hillman Solutions (NASDAQ:HLMN) Stock PriceMarketBeatNASDAQ:HLMNRead Canaccord Genuity Group Issues Pessimistic Forecast for Hillman Solutions (NASDAQ:HLMN) Stock Price2 hours agoFreshworks (NASDAQ:FRSH) Given New $17.00 Price Target at Canaccord Genuity GroupMarketBeatNASDAQ:FRSHRead Freshworks (NASDAQ:FRSH) Given New $17.00 Price Target at Canaccord Genuity Group2 hours agoCeriBell (NASDAQ:CBLL) Stock Price Target Raised at Canaccord Genuity GroupMarketBeatNASDAQ:CBLLRead CeriBell (NASDAQ:CBLL) Stock Price Target Raised at Canaccord Genuity Group2 hours agoBeam Therapeutics (NASDAQ:BEAM) Given New $78.00 Price Target at Canaccord Genuity GroupMarketBeatNASDAQ:BEAMRead Beam Therapeutics (NASDAQ:BEAM) Given New $78.00 Price Target at Canaccord Genuity Group2 hours agoAtriCure (NASDAQ:ATRC) Stock Price Expected to Rise, Canaccord Genuity Group Analyst SaysMarketBeatNASDAQ:ATRCRead AtriCure (NASDAQ:ATRC) Stock Price Expected to Rise, Canaccord Genuity Group Analyst Says2 hours agoCanaccord Genuity Group Has Lowered Expectations for DigitalOcean (NYSE:DOCN) Stock PriceMarketBeatNYSE:DOCNRead Canaccord Genuity Group Has Lowered Expectations for DigitalOcean (NYSE:DOCN) Stock Price2 hours agoPan American Silver (NYSE:PAAS) Issues Quarterly Earnings Results, Beats Expectations By $0.03 EPSMarketBeatNYSE:PAASRead Pan American Silver (NYSE:PAAS) Issues Quarterly Earnings Results, Beats Expectations By $0.03 EPS2 hours agoKinetik (NYSE:KNTK) Announces Quarterly Earnings Results, Misses Estimates By $0.14 EPSMarketBeatNYSE:KNTKRead Kinetik (NYSE:KNTK) Announces Quarterly Earnings Results, Misses Estimates By $0.14 EPS2 hours agoUBS Group Has Lowered Expectations for Grupo Televisa (NYSE:TV) Stock PriceMarketBeatNYSE:TVRead UBS Group Has Lowered Expectations for Grupo Televisa (NYSE:TV) Stock Price2 hours agoStevanato Group (NYSE:STVN) Stock Price Target Cut by UBS GroupMarketBeatNYSE:STVNRead Stevanato Group (NYSE:STVN) Stock Price Target Cut by UBS Group2 hours agoUBS Group Issues Pessimistic Forecast for Revolve Group (NYSE:RVLV) Stock PriceMarketBeatNYSE:RVLVRead UBS Group Issues Pessimistic Forecast for Revolve Group (NYSE:RVLV) Stock Price2 hours agoEMCOR Group (NYSE:EME) Price Target Cut to $925.00 by Analysts at UBS GroupMarketBeatNYSE:EMERead EMCOR Group (NYSE:EME) Price Target Cut to $925.00 by Analysts at UBS Group2 hours agoUBS Group Issues Pessimistic Forecast for Dynatrace (NYSE:DT) Stock PriceMarketBeatNYSE:DTRead UBS Group Issues Pessimistic Forecast for Dynatrace (NYSE:DT) Stock Price2 hours agoDigitalOcean (NYSE:DOCN) Given New $100.00 Price Target at UBS GroupMarketBeatNYSE:DOCNRead DigitalOcean (NYSE:DOCN) Given New $100.00 Price Target at UBS Group2 hours agoChemours (NYSE:CC) Stock Price Target Cut by UBS GroupMarketBeatNYSE:CCRead Chemours (NYSE:CC) Stock Price Target Cut by UBS Group2 hours agoCabot (NYSE:CBT) Price Target Cut to $80.00 by Analysts at UBS GroupMarketBeatNYSE:CBTRead Cabot (NYSE:CBT) Price Target Cut to $80.00 by Analysts at UBS Group2 hours agoUBS Group Issues Positive Forecast for Xometry (NASDAQ:XMTR) Stock PriceMarketBeatNASDAQ:XMTRRead UBS Group Issues Positive Forecast for Xometry (NASDAQ:XMTR) Stock Price2 hours agoSilver Standard Resources (NASDAQ:SSRM) Stock Gets Price Target Trim from UBS GroupMarketBeatNASDAQ:SSRMRead Silver Standard Resources (NASDAQ:SSRM) Stock Gets Price Target Trim from UBS Group2 hours agoBioNTech (NASDAQ:BNTX) Stock Price Target Lowered at UBS GroupMarketBeatNASDAQ:BNTXRead BioNTech (NASDAQ:BNTX) Stock Price Target Lowered at UBS Group2 hours agoAdaptHealth (NASDAQ:AHCO) Stock Price Target Cut by UBS GroupMarketBeatNASDAQ:AHCORead AdaptHealth (NASDAQ:AHCO) Stock Price Target Cut by UBS Group2 hours agoSera Prognostics (NASDAQ:SERA) Issues Earnings ResultsMarketBeatNASDAQ:SERARead Sera Prognostics (NASDAQ:SERA) Issues Earnings Results2 hours agoSezzle (NASDAQ:SEZL) Announces Earnings ResultsMarketBeatNASDAQ:SEZLRead Sezzle (NASDAQ:SEZL) Announces Earnings Results Featured Articles and OffersAbbVie's Humira Era Is Fading, But Its New Growth Engines Face Another TestBy Thomas Hughes | November 2, 2026My public warning after 55 years of watching the marketsFrom Weiss Ratings (Ad)Phillips 66 Posts Strong Earnings But the Stock Doesn't CareBy Chris Markoch | October 29, 2026Marriott's Earnings Beat Shows Why It's More Than a Bet on Travel DemandBy Chris Markoch | November 3, 2026Why JFrog Could Be the Software Infrastructure Company to Beat in the AI BoomBy Nathan Reiff | October 31, 2026Bank of America: 'Digital Dollar Inevitable'From Decentralized Masters (Ad)Marvell Eyes a Swing for the AI Networking Fences as Markets Weigh Lumentum Price TagBy Leo Miller | November 1, 20263 Waste Services Stocks With More Growth Than You Might ExpectBy Nathan Reiff | November 2, 2026 Alert CategoriesAll AlertsAnalystCongressional TradesConsensusCorporate BuybackCorporate Event TranscriptStock ListDividendEarningsEarnings PreviewEarnings Transcript HighlightsEstimatesGuidanceInsider TradeLockup ExpirationMarketBeat List ArticlesOptionsPriceSEC FilingStock Split Page 1 of 408 1234567 Earlier › Earliest » Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
